Search
for
Sort by
Research 421–450 of 1000+
- The evolution of primary multimodality treatment in resectable breast cancer
- Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration
- Male-pattern baldness and incident coronary heart disease and risk factors in the Heinz Nixdorf Recall Study
- Topical Treatments for Scalp Psoriasis
- Small Intestinal Organoid-Derived SP Cells Contribute to Repair of Irradiation-Induced Skin Injury
- Hair Repair Surgery
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Out/Performing Our Selves: Invitation for Dialogue
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial
- The Critical Roles of Serum/Glucocorticoid-Regulated Kinase 3 (SGK3) in the Hair Follicle Morphogenesis and Homeostasis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner
- Transgender and Migraine
- Hairline Lowering Surgery With Bone Tunneling Suture Fixation: Effectiveness and Safety in 91 Patients
- Novel <i>ABCD1</i> Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum
- Hair Loss Induced by Lopinavir-Ritonavir
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Incidence and risk factors for alopecia in survivors of critical illness: A multi-centre observational study
- Hyperadrenocorticism in Ferrets
- Endocrine evaluation of hirsutism
- Rituximab for Bone Lymphoma
- Platelet-rich fibrin in the management of oral mucosal lesions: a scoping review
- Platelet-rich plasma, a promising adjunctive treatment for vitiligo: A case report
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Ottawa, Ontario, Canada, February 13–16, 2013
- Menopause
- RADIUM POISONING